Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

Bennouna J, Sastre J, Arnold D, Г–sterlund P, Greil R, Van Cutsem E, von Moos R, ViГ©itez JM, BouchГ© O, Borg C, Steffens CC, Alonso-OrduГ±a V, Schlichting C, Reyes-Rivera I, Bendahmane B, AndrГ© T, Kubicka S

http://www.ncbi.nlm.nih.gov/pubmed/23168366